-
-
-
-
-
-
-
Fresh Tracks Therapeutics (FRTX) Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02
-
-
-
-
-
-
-
Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

